辉瑞以史上最大 ADC 并购案——430 亿美元收购 Seagen 后，艾伯维 101 亿、强生 20 亿、罗氏 10 亿，各家纷纷押注 ADC 赛道。今年依然热度不减，大冢制药 11 亿买入，罗氏再度加码 ADC 斥资 10 亿美元牵手 ...

Pfizer’s Mylotarg is back on the US market after a ... acute myeloid leukaemia patients whose tumours express the CD33 antigen, and adults and children two years and older with relapsed or ...

The committee voted 6-1 that Mylotarg in combination with chemotherapy has a favourable risk-benefit profile for patients with newly-diagnosed CD33-positive AML. The FDA is not bound to follow its ...